Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.7%

4 terminated/withdrawn out of 150 trials

Success Rate

89.7%

+3.2% vs industry average

Late-Stage Pipeline

9%

14 trials in Phase 3/4

Results Transparency

0%

0 of 35 completed trials have results

Key Signals

27 recruiting

Enrollment Performance

Analytics

N/A
47(38.5%)
Phase 1
36(29.5%)
Phase 2
18(14.8%)
Phase 4
10(8.2%)
Early Phase 1
7(5.7%)
Phase 3
4(3.3%)
122Total
N/A(47)
Phase 1(36)
Phase 2(18)
Phase 4(10)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (150)

Showing 20 of 150 trials
NCT07846592Not Yet Recruiting

Real-time Fluorescence Microscopy for Intraoperative Assessment of Prostate Biopsy Cores (FLASH)

Role: lead

NCT07846579Phase 4Not Yet Recruiting

Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial)

Role: lead

NCT05638776Phase 2Completed

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy

Role: collaborator

NCT07815483Not Yet Recruiting

A Multicenter Cohort Study of AI-Based Methods for Pulmonary Nodule Diagnosis and Follow-up

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT07002476Phase 3Recruiting

Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion

Role: lead

NCT07778368Phase 2Not Yet Recruiting

A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma

Role: lead

NCT05818098Not ApplicableCompleted

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

Role: collaborator

NCT03491709Phase 1Completed

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Role: collaborator

NCT03908814Phase 1Completed

Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors

Role: collaborator

NCT07678866Recruiting

A Preliminary Clinical Study Protocol for Evaluating the Efficacy and Safety of Pulse Electric Field Ablation Systems in Treating Adult Type 2 Diabetes Mellitus With Suboptimal Drug Control

Role: lead

NCT07600216Not ApplicableNot Yet Recruiting

A Multicenter, Randomized Controlled Superiority Trial Comparing Robotic-Assisted Versus Expert Cognitive Fusion Prostate Biopsy in Obese Men

Role: lead

NCT07516223Not ApplicableRecruiting

MRI-Assisted Guidance for Non-Essential Tissue Sampling

Role: lead

NCT06263205Not ApplicableCompleted

Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery

Role: collaborator

NCT07654634Enrolling By Invitation

Precision Antithrombotic Therapy

Role: collaborator

NCT06482645Not ApplicableRecruiting

Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer

Role: collaborator

NCT04053205Phase 1Completed

A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Role: collaborator

NCT07572097Not ApplicableNot Yet Recruiting

High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia

Role: lead

NCT05306145Not ApplicableCompleted

Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia

Role: lead

NCT07469982Phase 1Recruiting

A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors

Role: collaborator